CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
1.210
-0.010 (-0.82%)
At close: Nov 13, 2026, 4:00 PM EST
1.320
+0.110 (9.09%)
After-hours: Nov 13, 2026, 7:45 PM EST
CalciMedica Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4.57 | 11.52 | 7.94 | 5.53 | 1.33 | 4.76 |
Short-Term Investments | 9.19 | 1.5 | 10.73 | 5.71 | - | - |
Cash & Short-Term Investments | 13.77 | 13.02 | 18.67 | 11.24 | 1.33 | 4.76 |
Cash Growth | -2.24% | -30.28% | 66.12% | 746.87% | -72.13% | -3.39% |
Prepaid Expenses | 0.45 | 0.46 | 1 | 0.37 | 0.25 | 0.17 |
Restricted Cash | - | - | - | - | 0.15 | - |
Other Current Assets | - | 0.05 | - | - | - | - |
Total Current Assets | 14.22 | 13.53 | 19.67 | 11.61 | 1.73 | 4.93 |
Property, Plant & Equipment | 0.07 | 0.05 | 0.12 | 0.17 | 0.2 | 0.39 |
Long-Term Deferred Charges | - | - | - | - | - | 1.11 |
Other Long-Term Assets | 0 | 0.01 | 0.01 | 0.41 | 1.42 | 0.04 |
Total Assets | 14.29 | 13.59 | 19.79 | 12.19 | 3.35 | 6.46 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.02 | 1.16 | 2 | 1.42 | 2.87 | 1.93 |
Accrued Expenses | 1.85 | 1.37 | 1.69 | 2.61 | 1.72 | 1.83 |
Current Portion of Long-Term Debt | - | 1.25 | - | - | - | - |
Current Portion of Leases | - | - | - | - | - | 0.16 |
Other Current Liabilities | - | - | - | - | 0.2 | - |
Total Current Liabilities | 2.87 | 3.78 | 3.68 | 4.03 | 4.78 | 3.92 |
Long-Term Debt | 6.9 | 8.45 | - | - | - | - |
Long-Term Leases | - | - | - | - | - | 0.04 |
Other Long-Term Liabilities | 0.3 | 8 | 1.7 | - | 7.8 | 4.42 |
Total Liabilities | 10.07 | 20.23 | 5.38 | 4.03 | 12.58 | 8.38 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 197.91 | 182.68 | 174.17 | 154.22 | 40.4 | 39.89 |
Retained Earnings | -193.68 | -189.33 | -159.76 | -146.06 | -111.71 | -103.88 |
Comprehensive Income & Other | -0.01 | - | 0 | 0 | - | - |
Total Common Equity | 4.23 | -6.64 | 14.41 | 8.16 | -71.3 | -63.99 |
Shareholders' Equity | 4.23 | -6.64 | 14.41 | 8.16 | -9.23 | -1.92 |
Total Liabilities & Equity | 14.29 | 13.59 | 19.79 | 12.19 | 3.35 | 6.46 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 6.9 | 9.7 | - | - | - | 0.2 |
Net Cash (Debt) | 6.87 | 3.32 | 18.67 | 11.24 | 1.33 | 4.57 |
Net Cash Growth | 32.48% | -82.24% | 66.12% | 746.87% | -70.94% | -7.35% |
Net Cash Per Share | 1.62 | 1.10 | 8.30 | 12.52 | 80.67 | 8.41 |
Filing Date Shares Outstanding | 6.89 | 3.15 | 2.7 | 2.15 | 2.92 | 2.92 |
Total Common Shares Outstanding | 6.89 | 3.09 | 2.7 | 1.15 | 2.92 | 2.73 |
Working Capital | 11.35 | 9.75 | 15.98 | 7.58 | -3.05 | 1.01 |
Book Value Per Share | 0.61 | -2.15 | 5.34 | 7.09 | -24.40 | -23.47 |
Tangible Book Value | 4.23 | -6.64 | 14.41 | 8.16 | -71.3 | -63.99 |
Tangible Book Value Per Share | 0.61 | -2.15 | 5.34 | 7.09 | -24.40 | -23.47 |
Machinery | - | - | - | - | - | 0.24 |